Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Foshan Radiopharmaceutical is a specialized Chinese pharmaceutical company focused on the development, production, and distribution of radioactive drugs for diagnostic and therapeutic use. Established as one of the early pioneers in China's nuclear medicine industry, the company provides a range of essential radiopharmaceuticals, including Iodine-131 and Technetium-99m generators, used primarily in oncology and endocrinology. The company operates manufacturing facilities that comply with national GMP standards for radioactive materials, serving hospitals and medical centers across China. Its product portfolio supports critical medical procedures such as thyroid imaging, cancer treatment, and bone scans.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Foshan Radio Pharmaceutical.